Richard Bottner, PA-C
Project Name: “Buprenorphine Induction For Hospitalized Patients”
This award supports the Buprenorphine Team at Dell Seton Medical Center (DSMC) at the University of Texas at Austin, a 211-bed safety net hospital and the main teaching hospital for the Dell Medical School. From October 2016 through September 2017, over 270 admitted patients carried a diagnosis of opioid use dependency. The hospital setting provides a unique opportunity to deliver education and offer patients treatment with buprenorphine. Given that patients may be hospitalized for several days or weeks at a time, and may be at various stages of dependency during this time, the inpatient setting is an important time to offer treatment to this captive audience. Several barriers exist to starting buprenorphine therapy in the hospital setting. Clinicians, especially inpatient providers, often lack experience with substance abuse disorders, and have less comfort when dealing with opioid dependency beyond acute withdrawal symptoms. A stigma exists both around patients with opioid dependency as well as its primary treatments such as methadone and buprenorphine. Buprenorphine induction is offered through the Buprenorphine Team. This interprofessional and multidisciplinary group works to screen appropriate patients for buprenorphine induction, initiate this treatment while patients are hospitalized, facilitate linkage with an outpatient maintenance clinic, and provide institutional education in an effort to reduce stigma and raise awareness.
Debra Newman, PA-C, MPAS, MPH
Project Name: “Utilizing Psychiatric PAs in Drug/Treatment Courts: A Critical Look At Northern New Mexico”
The Santa Fe County Drug Court is the 3rd longest running drug court in the state of NM, and the Treatment Court is one of only five such courts in the state. The average cost per client/day is roughly $35 as compared to $100-$200/day in jail or prison. The Drug Court model encompasses evidence-based best practices to reduce recidivism and provide clients with psychiatric and addiction medicine treatment. This includes random UDS, group and individual therapy, moral reconation therapy, MAT, contingency management, graduated incentives, and sanctions.
Since 2007, psychiatrists have served as treatment providers for Santa Fe and Rio Arriba County Drug/Treatment Courts. Beginning in November, 2017, a psychiatric PA assumed this role, incorporating NIDA best practices along with publications to share with clients for improved treatment success. This was a result of the DATA waiver that permitted advanced practice clinicians the ability to prescribe MAT to appropriate patients after completion of training.
Clients served by Santa Fe and Rio Arriba Drug/Treatment Court can benefit from the services of a DATA waiver trained/certified and skilled psychiatric PA using evidence-based tools to help them successfully graduate from drug court and assume a drug-free lifestyle.
James Anderson, MPAS, PA-C, DFAAPA
Project Name: “Meeting the Need: Optimizing the Utilization of Physician Assistants (PAs) in Opioid Treatment Programs”
Current SAMHSA policy specifies that only physicians may admit patients and write medication orders in federally approved opioid treatment programs. In April of 2015, SAMHSA announced a process whereby opioid treatment programs could request an exemption to the guidelines, allowing PAs (and NPs) to be approved by SAMHSA to fully function in federally-approved opioid treatment program settings. This process is widely unknown and underutilized. In order to increase PA utilization in opioid treatment programs and increase the availability of medicated-assisted treatment in such settings, this project will identify and promote resources to assist PAs in navigating the SAMHSA exemption process. The project will illustrate the scope of the opioid epidemic, underscore the need for increased treatment opportunities for patients with opioid use disorders, examine the evidence about the effectiveness of medication-assisted treatment in opioid treatment programs, and increase the opportunities for PAs to participate in the much-needed care modality.
As the nationwide opioid epidemic continues, the enhancement of PA utilization in opioid treatment programs is essential in reducing the extensive morbidity and mortality related to opioid use disorders. This project will do so by increasing PA awareness of the treatment of opioid use disorders; conducting an evidence-based literature about opioid use disorders and in the role of PAs in treating opioid use disorders; mapping the opportunities to participate in opioid treatment programs; enhancing networks of PAs interested in participating in opioid treatment program-based care; and identifying and connecting other stakeholders in such an effort.
Sandra Alexander, PA-C
Project Name: “Carolina Partners in Mental HealthCare Recovery Services Pilot Program”
Due to variable structure of office-based opioid treatment (OBOT) centers, some patients that were in more regimented programs such as a detoxification center or federal opioid treatment programs (OTPs) that step down to office-based opioid treatment or treatment for their substance use disorder have been witnessed to have difficulty with the lack of structure in these environments, either relapsing and returning to the previous more structured environment or back onto the street without care.
The goal of the project is to plan and follow an implementation strategy for an integrated recovery services program that can be easily adapted at other locations to facilitate the expansion of a structured, patient-centered integrated office-based opioid treatment and co-occurring disorders program, providing the community with a program designed as a step-down facility from detoxification center or OTP.